Role of liver biopsy in the management of patients with hepatitis C virus chronic infection;Interet de la biopsie hepatique dans la prise en charge des malades ayant une infection chronique par le virus de l'hepatite C

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 1 BIS, 1997, Pages

  Deugnier, Yves ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

chronic hepatitis; hepatitis C virus; liver biopsy

Indexed keywords

CHRONIC HEPATITIS; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; MEDICAL DECISION MAKING; RECURRENT INFECTION; VIREMIA;

EID: 0030900185     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Schmid M, Pirovino M, Altofer J, Gudat F, Bianchi L. Acute hepatitis non-A, non-B: are there any specifie light microscopic features ? Liver 1982;2:1-67.
2. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986;2:165-73.
3. Chuah SY, Moody GA, Wicks AC, Mayberry JF. Nationwide survey of liver biopsy. Is there a need to increase resources, manpower and training ? Hepatogastroenterology 1994;41:4-8.
4. Froehlich F, Lamy O, Fried M, Gonvers JJ. Practice and complications of liver biopsy Results of a nationwide survey in Switzerland. Dig Dis Sci 1993;38:1480-4.
5. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995;36:437-41.
6. McGill D, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396-400.
7. DeGroote J, Desmet V, Gedigk P, Korb G, Popper H, Poulsen H. A classification for chronic hepatitis. Lancet 1968;2:626-8.
8. Review by an international group. Acute and chronic hepatitis revisited. Lancet 1977;2:914-9.
9. Knodell K, Ishak K, Black W, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;5:431-5.
10. Desmet V, Gerber MA, Hoofnagle JH, Manns MP, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
11. Bedossa P. Présentation d'une grille d'analyse informatisée pour le recueil des lésions histopathologiques dans l'hépatite chronique virale C. Etude coopérative du groupe METAVIR. Ann Pathol 1993;13:260-5.
12. Scheuer PJ. The nomenclature of chronic hepatitis: time for change. J Hepatol 1995;22:112-4.
13. Ludwig J. The nomenclature of chronic hepatitis: an obituary, Gastroenterology 1993;105:274-8.
14. METAVIR. Quelle classification pour les hépatites chroniques? Les leçons du virus de l'hépatite C. Gastroenterol Clin Biol 1994;18:403-6.
15. METAVIR. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
16. Bédossa P, Poynard T, and the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-93.
17. Deugnier Y. Histopathologie des hépatites virales C. In: Degos F, Dhumeaux D, Trépo C, eds. L'hépatite C. Paris: Imprimerie Nationale, Direction Générale de la Santé, 1996:31-8.
18. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune hepatitis: a comparative study. Hepatology 1992;15:572-7.
19. Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC, et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology 1993;104:595-603.
20. Mosnier JF, Degott C, Marcellin P, Hénin D, Erlinger S, Benhamou JP. The intraportal lymphoid nodule and its environment in chronic hepatitis C: an immunohistochemical study. Hepatology 1993;17:366-71.
21. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992;15:567-71.
22. Carré D, Boucher E, Turlin B, Guyader D, Brissot P, Deugnier Y. Baisse de la cholestérolémie et de l'apolipoprotéinc B au cours des hépatites chroniques virales C avec stéatose massive. Gastroenterol Clin Biol 1994;18:899-900.
23. Dienes H, Popper H, Arnold W, Lobeck H. Histologic observations in human hepatitis non-A, non-B. Hepatology 1982;2:562-71.
24. Brillanti S, Masci C, Siringo S, Di Febo G, Miglioli M, Barbara L. Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J Hepatol 1991;13:347-50.
25. Poynard T, Bédossa P, Opolon P, METAVIR group, CLINIVIR group, and DOSVIRC group. Natural history of liver fibrosis progression in patients with chronic hepatitis. Modelization based on 2,235 liver biopsies (abstract). Hepatology 1996;24:249A.
26. Fargion S, Pipemo A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, et al. Hepatitis-C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1995;21: 1754-5.
27. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-13.
28. Boucher E, Bourienne A, Turlin B, Moirand R, Brissot P, Deugnier Y. Reduction of liver iron content following treatment of chronic hepatitis C. Gut 1997 (in press).
29. Olynyk JK, Reddy KR, Di Bisceglie A, Jetters LJ, Parker TI, Radick JL, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995;108:1104-9.
30. Deugnier Y, Loréal O, Turlin B, Guyader D, Jouanolle H, Moirand R, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bio-clinical correlations. Gastroenterology 1992;102:2050-9.
31. Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992;16:273-81.
32. Takahashi M, Yamada G, Miyamoto R, Toshihiko D, Endo H, Tsujii T. Natural course of hepatitis C. Am J Gastroenterol 1993;88:240-3.
33. Yano M, Kumuda H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long-term pathological evolution of chronic hepatitis C Hepatology 1996;23:1334-40.
34. Payen JL, Izopet J. Le statut de porteur sain du virus de l'hépatite C existe-t-il ? Gastroenterol Clin Biol 1996;20:531-4.
35. Serfaty L, Chazoullières O, Pawlotsky JM, Andréani T, Pellet C, Poupon R. Interferon alpha therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996;110:291-5.
36. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, et al. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 1994;19:871-5.
37. Shindo M, Arai K, Okuno T. The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. Hepatology 1995;22:418-25.
38. Saracco G, Rosina F, Abate ML, Chiandussi L, Gallo V, Cerutti E, et al. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b. Hepatology 1993;18:1300-5.
39. Boyer N, Marcellin P, Duchatelle V, Martinot M, Kilani A, Pouteau M, et al. Sustained response after alpha-interferon therapy in patients with chronic hepatitis C (abstract). Hepatology 1995;22:291A.
40. Reichard O, Glaumann H, Fryden A, Norkrans G, Schvarcz R, Sonnerborg A, et al. Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology 1995;21:918-22.
41. Mathurin P, Thévenol T, Sobewski R, Moussali J, Charlotte F, Opolon P, et al. Six months with interferon alpha (IFN) decrease the progression of liver fibrosis and activity in patients with chronic hepatitis without normalization of ALT at 3 months (NR-3M) (abstract). Hepatology 1996;24:157A.